Publications
Download CSV
Download XLSX
Download TXT
Tables
2023 (121)
2022 (712)
2021 (1400)
2020 (843)
All (3076)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Lancet Diabetes Endocrinol
JSON
ISSN
2213-8595
ISSN-L
-
IUID
78808565e9684329bfc220278c666263
Modified
2021-04-06T10:40:59.334Z
Created
2021-04-06T10:40:59.334Z
Year 2021
PubMed
DOI
Crossref
Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply.
Kosiborod MN, Esterline R, Oscarsson J, ..., Verma S, Berwanger O
Lancet Diabetes Endocrinol
-
(-) - [2021-12-15; online 2021-12-15]
Type: Other
PubMed
DOI
Crossref
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kosiborod MN, Esterline R, Furtado RHM, ..., Nigro Maia L, Berwanger O
Lancet Diabetes Endocrinol
-
(-) - [2021-07-21; online 2021-07-21]
Category: Biochemistry
Category: Drug Discovery
Type: Journal article
PubMed
DOI
Crossref
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials.
Jolliffe DA, Camargo CA, Sluyter JD, ..., Urashima M, Martineau AR
Lancet Diabetes Endocrinol
-
(-) - [2021-03-30; online 2021-03-30]
Category: Health
Type: Journal article
SciLifeLab Data Centre
Publications
9.5.0